AzTrials
AzTrials

Low Back PainPROGRESSNCT06030570

Effect of an Interdisciplinary Spine Rehabilitation Program

An observational study of Low Back Pain and Spine Disease, run by KU Leuven at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this research project is to evaluate the effectiveness of the current interdisciplinary rehabilitation program (Revita) and follow-up trajectory for chronic lumbar spine disorders in the University Hospitals Leuven. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Low Back Pain, Spine Disease
What is being tested?
Rehabilitation program (Revita)
How many people
90 participants
Where
1 siteBelgium
Study dates
22 Aug 2023to Dec 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with chronic spine problems in which a multidisciplinary approach is needed

Who may be able to join

  • Adults, age > 18 years
  • Spine problem for > 6 weeks, needing interdisciplinary care (risk factors, failure of first line treatment, etc)
  • Informed consent to participate

Who cannot join

  • Patients without sufficient understanding of the Dutch language
  • Unable to participate in 2h rehabilitation sessions with exercises

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sofie Rummens, MD contact

003216338700

sofie.rummens@uzleuven.be

Belgium1 site, 1 recruiting
  • University Hospitals Leuven

    Leuven, 3000

    Sofie Rummens, MD, sofie.rummens@uzleuven.be

    Recruiting

Other trials in Belgium

About this study

Official title: PROGRESS: The Effect of an Interdisciplinary Program for Rehabilitation for Spinal Disorders

The goal of this research project is to evaluate the effectiveness of the current interdisciplinary rehabilitation program (Revita) and follow-up trajectory for chronic lumbar spine disorders in the University Hospitals Leuven.

Being tested
Rehabilitation program (Revita)
Medical subject headings
Low Back Pain, Spinal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rehabilitation program (Revita)Other

    Multidisciplinary programs in an outpatient hospital setting are coordinated by specialists in Physical and Rehabilitation Medicine. These programs combine a physical part (e.g., specific exercises, manual techniques) with at least one other element (psychological, social, educational or occupational intervention). In a multidisciplinary spine rehabilitation program, a maximum of 36 sessions over a maximum time period of 6 months is offered. Afterwards, a (monodisciplinary) follow-up trajectory (K15) is possible, consisting of maximum 104 sessions a year.

Study groups in NCT06030570
Study groupRoleWhat they receive
Subjects with low back painPatients of University Hospitals Leuven participating in the interdisciplinary spine rehabilitation program (REVITA)
Receives: Other: Rehabilitation program (Revita)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Oswestry Disability Index (ODI)

    Change in functional impairment (before vs. after rehabilitation program)

    minimum score: 0 maximum score: 100 a higher score corresponds with more functional impairment

    Measured: baseline - 6 months - 1 year

  2. Change in pain

    Change in numeric rating scale (NRS) for low back/leg pain (before vs. after rehabilitation program)

    minimum score: 0 maximum score: 10 a higher score corresponds with more pain

    Measured: baseline - 6 months - 1 year

Secondary outcomes (11)
  1. Effect on quality of life

    Change in EuroQoL 5D (before vs. after rehabilitation program)

    5 items with 3 levels Scale to assess health: 0-100 a higher score corresponds with better health

    Measured: baseline - 6 months - 1 year

  2. Effect on risk stratification tool

    Change in Örebro score (before vs. after rehabilitation program)

    minimum score: 0 maximum score: 100 a higher score corresponds with a higher risk profile

    Measured: baseline - 6 months - 1 year

  3. Effect on anxiety and depression

    Change in Hospital Anxiety and Depression Scale (HADS) (before vs. after rehabilitation program)

    minimum score: 0 maximum score: 21 (anxiety) - 21 (depression) a higher score corresponds with a higher suspicion for anxiety/depression

    Measured: baseline - 6 months - 1 year

  4. Effect on kinesiophobia

    Change in Tampa scale for Kinesiophobia (TSK) score (before vs. after rehabilitation program)

    minimum score: 17 maximum score: 68 a higher score corresponds with an increasing degree of kinesiophobia

    Measured: baseline - 6 months - 1 year

  5. Effect on fear-avoidance beliefs

    Change in Fear Avoidance Beliefs Questionnaire (FABQ) score (before vs. after rehabilitation program)

    minimum score: 0 maximum score: 96 a higher score corresponds with stronger fear avoidance beliefs

    Measured: baseline - 6 months - 1 year

  6. Effect on body awareness

    Change in Fremantle Back Awareness Scale Questionnaire score (before vs. after rehabilitation program)

    minimum score: 0 maximum score: 36 a higher score corresponds with a worse back-specific body perception

    Measured: baseline - 6 months - 1 year

  7. Treatment experience

    Patient Global impression of change (PGIC)

    minimum score: 1 maximum score: 7 a higher score corresponds with less impression of change

    Measured: 6 months - 1 year

  8. Return to Work self-efficacy

    "the Return to Work Self-Efficacy" questionnaire

    minimum score: 1 maximum score: 6 a higher score corresponds with a higher level of self-efficacy

    Measured: baseline - 6 months - 1 year

  9. Return to work

    number of days to return to work

    Measured: baseline - 6 months - 1 year

  10. Effect on functioning

    Change in Patient Specific Functional scale (PSFS)

    minimum score: 0 maximum score: 10 a higher score corresponds with a better functional level

    Measured: baseline - 6 months - 1 year

  11. Effect on medication use

    Change in Medication Quantification Scale (MQS)

    a higher score corresponds with a higher medication use

    Measured: baseline - 6 months - 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2023
  2. Study start22 Aug 2023
  3. Primary completionDec 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06030570
Sponsor's protocol ID
S67679
Acronym
PROGRESS
Status last verified
Sep 2025
First submitted
24 Aug 2023
Last updated
23 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Low Back Pain and Spine Disease, run by KU Leuven at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sofie Rummens, MD (003216338700, sofie.rummens@uzleuven.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Oswestry Disability Index (ODI) (time frame: baseline - 6 months - 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2025; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in